OCUL

6.96

4.53% -0.33

Dopo l'orario di chiusura: 6.98 0.02 +0.29%

Ocular Therapeutix Inc (OCUL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché OCUL Giù? Forum Previsione

Precedente Chiudi:

$7.29

Aprire:

$7.4

Volume 24 ore:

4.95M

Relative Volume:

1.86

Capitalizzazione di mercato:

$1.53B

Reddito:

$52.04M

Utile/perdita netta:

$-290.50M

Rapporto P/E:

-4.7812

EPS:

-1.4557

Flusso di cassa netto:

$-240.94M

1 W Prestazione:

-27.88%

1M Prestazione:

-36.15%

6M Prestazione:

-18.02%

1 anno Prestazione:

-37.07%

Intervallo 1D:

$6.935

$7.425

Intervallo di 1 settimana:

$6.935

$9.38

Portata 52W:

$6.2301

$16.44

Ocular Therapeutix Inc Stock (OCUL) Company Profile

Nome

Ocular Therapeutix Inc

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

781-357-4000

Indirizzo

14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA

Dipendente

325

Cinguettio

@OCUTX

Prossima data di guadagno

2026-11-03

Ultimi documenti SEC

OCUL's Discussions on Twitter

Compare OCUL vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OCUL Ocular Therapeutix Inc	6.96	2.12B	52.04M	-290.50M	-240.94M	-1.4557
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-15	Iniziato	Chardan Capital Markets	Buy
2025-04-08	Iniziato	William Blair	Outperform
2025-03-18	Iniziato	RBC Capital Mkts	Outperform
2025-03-11	Iniziato	Needham	Buy
2024-10-16	Iniziato	Scotiabank	Sector Outperform
2024-06-20	Aggiornamento	TD Cowen	Hold → Buy
2024-05-31	Ripresa	Piper Sandler	Overweight
2024-02-09	Iniziato	BofA Securities	Buy
2023-04-21	Iniziato	Robert W. Baird	Outperform
2022-08-10	Ripresa	Berenberg	Buy
2021-08-10	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-12-28	Downgrade	H.C. Wainwright	Buy → Neutral
2020-12-17	Iniziato	Berenberg	Buy
2020-11-13	Reiterato	Raymond James	Strong Buy
2020-08-10	Reiterato	H.C. Wainwright	Buy
2020-03-03	Aggiornamento	Raymond James	Outperform → Strong Buy
2019-05-21	Downgrade	Cowen	Outperform → Market Perform
2019-05-21	Reiterato	H.C. Wainwright	Buy
2019-05-21	Downgrade	Raymond James	Strong Buy → Outperform
2018-12-03	Reiterato	Cantor Fitzgerald	Overweight
2018-11-15	Iniziato	Raymond James	Strong Buy
2018-09-07	Iniziato	Piper Jaffray	Overweight
2017-10-24	Iniziato	Guggenheim	Buy
2017-07-26	Iniziato	H.C. Wainwright	Buy
2017-07-12	Reiterato	Cantor Fitzgerald	Overweight
2017-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2017-02-10	Iniziato	Cantor Fitzgerald	Overweight
2016-11-15	Reiterato	RBC Capital Mkts	Outperform
2016-08-11	Iniziato	JMP Securities	Mkt Outperform
2016-02-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2015-10-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2015-08-13	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie

Oct 01, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences - Yahoo Finance

Oct 01, 2026

Sep 29, 2026

Operating income of Ocular Therapeutix Inc – HAN:0OT - TradingView

Sep 29, 2026

RBC Capital reiterates Ocular Therapeutix stock rating on wAMD treatment potential - Investing.com Nigeria

Sep 29, 2026

ETFs Investing in Ocular Therapeutix Inc Stocks - TradingView

Sep 29, 2026

Sep 26, 2026

OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights - Stocktwits

Sep 26, 2026

Sep 25, 2026

Precision Trading with Ocular Therapeutix Inc. (OCUL) Risk Zones - Stock Traders Daily

Sep 25, 2026

Sep 24, 2026

OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda? - Stocktwits

Sep 24, 2026